1999
DOI: 10.1055/s-0037-1614595
|View full text |Cite
|
Sign up to set email alerts
|

Start of UK Confidential Haemophilia A Database: Analysis of 142 Patients by Solid Phase Fluorescent Chemical Cleavage of Mismatch

Abstract: SummaryA national strategy for optimising genetic services in haemophilia A has been initiated in the UK. Solid phase fluorescent chemical cleavage of mismatch is used to screen the entire coding region of factor VIII in six segments: four amplified from the trace of mRNA in blood lymphocytes and two from genomic DNA for the 3.4 kb exon 14 and flanking intron sequences. These segments are analysed in two threefold multiplexes so that the genes of 18 patients can be screened in a single ABI 377 gel. The promote… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
43
0

Year Published

2000
2000
2014
2014

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 48 publications
(49 citation statements)
references
References 32 publications
6
43
0
Order By: Relevance
“…Initially, polymorphisms contained within the FVIII gene, or closely linked to it, made it possible to carry out linkage studies in haemophilia families (reviewed in Peake et al, 1993); however, more recently, technical advances have permitted the characterization of causative mutations (Waseem et al, 1999) and direct mutation detection is the preferred route for family studies.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Initially, polymorphisms contained within the FVIII gene, or closely linked to it, made it possible to carry out linkage studies in haemophilia families (reviewed in Peake et al, 1993); however, more recently, technical advances have permitted the characterization of causative mutations (Waseem et al, 1999) and direct mutation detection is the preferred route for family studies.…”
Section: Discussionmentioning
confidence: 99%
“…Inclusion of loci with the highest frequency of heterozygosity and lowest degree of linkage disequilibrium maximizes the probability of an informative result. Such loci include two (CA)n microsatellites in intron 13 (Lalloz et al, 1991) and intron 22 (Lalloz et al, 1992) of the FVIII gene, a BclI restriction fragment length polymorphism (RFLP) in intron 18 (Gitschier et al, 1985) and an XbaI RFLP in intron 22 (Wion et al, 1986). The last is contained within a 9´5-kb stretch of sequence (int22h-1), which is repeated extragenically at Xq28 (int22h-2 and int22h-3) (Naylor et al, 1995).…”
Section: Discussionmentioning
confidence: 99%
“…12 From the Division of Medical and Molecular Genetics, Guy's, King's, and St Thomas' School of Medicine, London, United Kingdom. …”
Section: Blood Samplesmentioning
confidence: 99%
“…Common missense mutations in the A domain include Glu321Lys, Tyr346Cys, Val357Gly, Val376Gly, Thr770Ser, Thr751Ser Glu720Lys; all of the residues that are affected by these mutations lie either adjacent to or within the a1 or a2 acidic region (Stoilova-Mcphie et al, 2002;Goodeve et al, 2001;Mumfordet al, 2002). Other mutations that have contributed to understanding the structure-function relationship of F8 occur at the thrombin cleavage sites at Arg372 (Arg372Cys) (Pattinson et al, 1990;Vidal et al, 2002) and Arg372His (Jayandharan et al, 2005) and Arg1689 (Arg1689Cys) Cutler et al, 2002;Arai et al, 1990;Waseem et al, 1990;Hill Deam et al, 2005). Several mutations affect residues that are located at the interface of the A domains (Arg 282Ser, Ala284Glu and Arg531His at the A1-A2 interface, Ser289Leu at the A1-A3 interface, Asn694Ile, Arg698Trp and Arg698Leu at the A2-A3 interface).…”
Section: Mutations That Affect the A Domainsmentioning
confidence: 99%